Pharmaceutical Companies News


'Pharmaceutical Companies' - 29 News Result(s)

  • Self-certification for bar-coding for drug firms launched

    Self-certification for bar-coding for drug firms launched

    A barcode helps in tracking and tracing the origin of drugs which in turn helps in minimising chances of genuine drugs being considered spurious, sub-standard or counterfeit.

  • Pharma sales in India to touch $27 billion by 2016: Deloitte

    Pharma sales in India to touch $27 billion by 2016: Deloitte

    Pharmaceutical sales in India are expected to rise by 14.4 per cent to $27 billion in 2016 from last year, but the life sciences and health care industry is up against challenges such as quality management and meeting global standards, consultancy fi...

  • Lapses by some pharma companies overshadowed good things: FDA chief

    Lapses by some pharma companies overshadowed good things: FDA chief

    "Unfortunately, the many Indian companies that understand good manufacturing and quality processes have been overshadowed by recent lapses in quality at a handful of pharmaceutical firms," Hamburg, currently on an India trip, said in a blog posted on...

  • US drug regulator to hold quality requirement workshops across India

    US drug regulator to hold quality requirement workshops across India

    The US Food and Drug Administration plans to conduct workshops across India in the next one year in order to sanitise the countrys pharmaceutical companies about the changing quality requirements in the American market.

  • Sun Pharma, DRL, Cipla gain on defensive buying

    Sun Pharma, DRL, Cipla gain on defensive buying

    Shares of Indian pharmaceutical companies perceived as defensive gain on risk aversion after overseas investors sold Rs 267 crore worth of Indian shares on Friday, extending their selling streak to a seventh day, provisional exchange data shows, deal...

  • Big Pharma pushes for US action against India over patent worries: report

    Big Pharma pushes for US action against India over patent worries: report

    Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said.

  • Pharma companies to witness 26 per cent core sales growth in Q3: BofA-ML

    Pharma companies to witness 26 per cent core sales growth in Q3: BofA-ML

    Pharmaceutical companies may witness a core sales growth of 26 per cent in the third quarter of fiscal year 2014, according to a report by Bank of America-Merrill Lynch.

  • New pricing policy may impact domestic revenue of pharma firms in 2014: Dun & Bradstreet

    New pricing policy may impact domestic revenue of pharma firms in 2014: Dun & Bradstreet

    Implementation of the new pricing policy is likely to translate into weak domestic revenue generation for pharma companies in 2014, according to a report by global research firm Dun & Bradstreet.

  • European Commission fines pharmaceutical giants $22 million

    European Commission fines pharmaceutical giants $22 million

    In a statement, the Commission's antitrust chief, Joaquin Almunia, said the two companies "shockingly deprived patients in the Netherlands, including people suffering from cancer, from access to a cheaper version of this medicine."

  • Pharma sector in good health, to create more jobs: experts

    Pharma sector in good health, to create more jobs: experts

    The pharma industry in India has clocked double digit growth rate (about 14 per cent) in the last five years and this is expected to continue in 2014 too. Several multinational firms operate in this space, which has great scope for hiring and job cre...

  • Cabinet may restrict pharma FDI as drug costs rise

    Cabinet may restrict pharma FDI as drug costs rise

    The Cabinet will decide on FDI limit in existing pharmaceutical companies producing critical medicines.

  • Monaco invites Indian firms to invest in IT, pharma sectors

    Monaco invites Indian firms to invest in IT, pharma sectors

    Monaco government has invited Indian companies to invest in various sectors, including information technology, pharmaceuticals and real estate.

  • PE firm Actis says invests $48 million in Symbiotec Pharmalab

    PE firm Actis says invests $48 million in Symbiotec Pharmalab

    Symbiotec is a leading specialist producer of steroid- hormone active pharmaceutical ingredients and has over 200 customers, including large multinationals as well as generic pharmaceutical companies, Actis said in a statement.

  • Barcode procedures for pharma companies simplified

    Barcode procedures for pharma companies simplified

    A barcode helps in tracking and tracing of origin of drugs, which in turn helps in minimising the chances of genuine drugs being considered spurious, sub-standard or counterfeit.

  • Drug makers to get 15 days to respond to price revision: NPPA

    Drug makers to get 15 days to respond to price revision: NPPA

    The National Pharmaceutical Pricing Authority (NPPA) said it has been receiving representations from manufacturers seeking clarifications and corrections mainly with regard to applicability of price notifications on their products as well as regardin...

  • India pharma companies should follow strict regulations: FDA

    India pharma companies should follow strict regulations: FDA

    In its latest action against Indian drug makers, the US health regulator FDA had red- flagged "significant deviations" from good manufacturing practices by two Indian pharmaceutical companies: Hyderabad-based Posh Chemicals and Himachal Pradesh-based...

  • Indian drug makers face higher costs for sale in US

    Indian drug makers face higher costs for sale in US

    Many Indian drug makers will soon have to bear higher costs for sale of products in American markets, as the US Food and Drug Administration (FDA) is hiking the fees for generic drug makers by up to 48 per cent from October.

  • BSE Sensex flat; caution ahead of earnings

    BSE Sensex flat; caution ahead of earnings

    The BSE Sensex is flat as the rupee fails to gain after the Reserve Bank of India (RBI) asked state-run oil companies to purchase dollars from a single bank - a measure that is seen providing only near-term support.

  • Ranbaxy, Daiichi to leverage on brand strength for global markets

    Ranbaxy, Daiichi to leverage on brand strength for global markets

    In a bid to strengthen their hybrid business model, drug major Ranbaxy Laboratories and its parent firm Daiichi Sankyo will project only one of them as the face of the group in different global markets depending on their respective strengths.

  • Another bitter pill for Ranbaxy, this time from EU

    Another bitter pill for Ranbaxy, this time from EU

    The EU claims Ranbaxy and other international pharmaceutical companies blocked the delivery of cheap drugs to the EU market, despite an agreement to deliver. Also, European regulators have estimated that consumers are paying up to 20 per cent more fo...